Back to Screener

Healthcare

United Health Products, Inc.(UEEC)

Live Price

Offline

$0.0525

-6.25% today

1Y Change

-58.66%

Window

Jun 20, 2025 โ†’ Jun 17, 2026

Market Cap
$20.00M
Revenue Growth
0.0%
EPS Growth
-28.4%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 20, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

United Health Products, Inc. (UEEC) is a Healthcare stock with a market cap of $20.00M and listed on OTC. The stock last traded around $0.05 and down 58.7% across the available one-year price window (Jun 20, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -28.4%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -28.4%, free cash flow +0.7% with operating margin 0.0% and ROIC 123.1%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines UEEC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +7.6% peer median

Operating Margin

Below sector median

0.0% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 4, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at 0.0% and EPS is at -28.4%, with operating margin around 0.0%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -7.5% over the next 5 trading days and finished higher after 1 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
May 4, 2026
โ€”-23.6%-28.1%-36.0%
2026
Mar 26, 2026
โ€”+2.2%+8.7%+87.0%
2025
Nov 14, 2025
โ€”-12.7%-3.2%-4.8%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

UEEC

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

UEEC Max Drawdown

-65.35%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for UEEC and SPY.

Calendar-year return history is still loading or unavailable.
United Health Products, Inc. logo

Company Overview

United Health Products, Inc.

Other OTC

Mount Laurel, NV, US
Visit unitedhealthproductsinc.comCall IR877 358 3444

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, assisted living and nursing homes, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Henderson, Nevada.

Leadership
Brian D. Thom
IPO Date
Feb 14, 2007
Employees
7
Street Address
10624 South Eastern Avenue
Mailing
Mount Laurel, NV, 89052
Region
Mount Laurel, NV, US
Reporting Currency
USD
Investor Line
877 358 3444
Last Updated
May 5, 2026
CIK: 0001096938ISIN: US91059D1000CUSIP: 91059D100
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
โ€”
Price/Book
โ€”

Growth

Revenue
0.0%
EPS
-28.4%
Free Cash Flow
+0.7%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
80.6%
ROIC
123.1%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
0.03

Earnings Reports

๐Ÿ“… Last reportedMay 4, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 4, 26
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 26, 26
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 14, 25
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 14, 25
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 5, 25
-0.01
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 28, 25
-0.01
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 12, 24
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 13, 24
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 9, 24
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Apr 1, 24
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 13, 23
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 9, 23
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 8, 23
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 28, 23
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 14, 22
0.00
Est โ€”
โ€”
37.5B
Est โ€”
โ€”
โ€”
Aug 15, 22
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.

Explore the advanced chart guideRead how to compare stocks